These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 27014601)
1. Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics. Lai CY; Scarr E; Udawela M; Everall I; Chen WJ; Dean B World J Psychiatry; 2016 Mar; 6(1):102-17. PubMed ID: 27014601 [TBL] [Abstract][Full Text] [Related]
2. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study. Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557 [TBL] [Abstract][Full Text] [Related]
3. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Glatt SJ; Everall IP; Kremen WS; Corbeil J; Sásik R; Khanlou N; Han M; Liew CC; Tsuang MT Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15533-8. PubMed ID: 16223876 [TBL] [Abstract][Full Text] [Related]
4. Toward the identification of peripheral epigenetic biomarkers of schizophrenia. Guidotti A; Auta J; Davis JM; Dong E; Gavin DP; Grayson DR; Sharma RP; Smith RC; Tueting P; Zhubi A J Neurogenet; 2014; 28(1-2):41-52. PubMed ID: 24702539 [TBL] [Abstract][Full Text] [Related]
5. Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: Pathophysiological and phenotypic implications. Ali FT; Abd El-Azeem EM; Hamed MA; Ali MAM; Abd Al-Kader NM; Hassan EA Schizophr Res; 2017 Oct; 188():98-109. PubMed ID: 28100419 [TBL] [Abstract][Full Text] [Related]
6. Assessment of a combination of Serum Proteins as potential biomarkers to clinically predict Schizophrenia. Li C; Tao H; Yang X; Zhang X; Liu Y; Tang Y; Tang A Int J Med Sci; 2018; 15(9):900-906. PubMed ID: 30008602 [TBL] [Abstract][Full Text] [Related]
7. Schizophrenia and Glutathione: A Challenging Story. Carletti B; Banaj N; Piras F; Bossù P J Pers Med; 2023 Oct; 13(11):. PubMed ID: 38003841 [TBL] [Abstract][Full Text] [Related]
8. Recent Reports on Redox Stress-Induced Mitochondrial DNA Variations, Neuroglial Interactions, and NMDA Receptor System in Pathophysiology of Schizophrenia. Beeraka NM; Avila-Rodriguez MF; Aliev G Mol Neurobiol; 2022 Apr; 59(4):2472-2496. PubMed ID: 35083660 [TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
10. A preliminary analysis of LncRNA biomarkers for schizophrenia. Jia J; Liu X; Ma L; Xu Y; Ren Y Epigenomics; 2021 Sep; 13(18):1443-1458. PubMed ID: 34528440 [TBL] [Abstract][Full Text] [Related]
11. Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications. Fernandes BS; Steiner J; Berk M; Molendijk ML; Gonzalez-Pinto A; Turck CW; Nardin P; Gonçalves CA Mol Psychiatry; 2015 Sep; 20(9):1108-19. PubMed ID: 25266124 [TBL] [Abstract][Full Text] [Related]
13. Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia. Fond G; Micoulaud-Franchi JA; Faugere M; Boyer L; Faget-Agius C; Lançon C; Richieri R; Cermolacce M Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109800. PubMed ID: 31676465 [TBL] [Abstract][Full Text] [Related]
14. Molecular substrates of schizophrenia: homeostatic signaling to connectivity. Landek-Salgado MA; Faust TE; Sawa A Mol Psychiatry; 2016 Jan; 21(1):10-28. PubMed ID: 26390828 [TBL] [Abstract][Full Text] [Related]
15. Precision psychiatry with immunological and cognitive biomarkers: a multi-domain prediction for the diagnosis of bipolar disorder or schizophrenia using machine learning. Fernandes BS; Karmakar C; Tamouza R; Tran T; Yearwood J; Hamdani N; Laouamri H; Richard JR; Yolken R; Berk M; Venkatesh S; Leboyer M Transl Psychiatry; 2020 May; 10(1):162. PubMed ID: 32448868 [TBL] [Abstract][Full Text] [Related]
16. Schizophrenia and Epigenetic Aging Biomarkers: Increased Mortality, Reduced Cancer Risk, and Unique Clozapine Effects. Higgins-Chen AT; Boks MP; Vinkers CH; Kahn RS; Levine ME Biol Psychiatry; 2020 Aug; 88(3):224-235. PubMed ID: 32199607 [TBL] [Abstract][Full Text] [Related]
17. Neuroimage Analysis Methods and Artificial Intelligence Techniques for Reliable Biomarkers and Accurate Diagnosis of Schizophrenia: Achievements Made by Chinese Scholars Around the Past Decade. Du Y; Niu J; Xing Y; Li B; Calhoun VD Schizophr Bull; 2024 Jul; ():. PubMed ID: 38982882 [TBL] [Abstract][Full Text] [Related]
19. Charting the proteome landscape in major psychiatric disorders: From biomarkers to biological pathways towards drug discovery. Fernandes BS; Dai Y; Jia P; Zhao Z Eur Neuropsychopharmacol; 2022 Aug; 61():43-59. PubMed ID: 35763977 [TBL] [Abstract][Full Text] [Related]
20. Evidence for increased DNA damage repair in the postmortem brain of the high stress-response group of schizophrenia. Shishido R; Kunii Y; Hino M; Izumi R; Nagaoka A; Hayashi H; Kakita A; Tomita H; Yabe H Front Psychiatry; 2023; 14():1183696. PubMed ID: 37674553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]